Oramed Pharmaceuticals (ORMP) Q3 2025 Earnings — Beat Estimates

Screener

Reported November 13, 2025 · Before market open

EPS$1.13Beat by $1.17

EPS estimate-$0.04

Next report

Nov 12, 2026 (in 2 months)

EPS estimate$0.43

Versus estimates

Revenue

Diluted EPS

Q2 2026-$0.09Miss by $0.52 Q1 2026-$0.16 Q4 2025-$0.06Beat by $0.02

Q3 2025$1.13Beat by $1.17

Q2 2025-$0.05Miss by $0.01 Q1 2025-$0.19Miss by $0.16

FAQ

When did Oramed Pharmaceuticals report Q3 2025 earnings?: Oramed Pharmaceuticals (ORMP) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Oramed Pharmaceuticals's Q3 2025 revenue and EPS?: Oramed Pharmaceuticals reported eps of $1.13 for Q3 2025.
Did Oramed Pharmaceuticals beat estimates in Q3 2025?: EPS beat the consensus estimate of $-0.04 by $1.17.
Where can I find Oramed Pharmaceuticals's Q3 2025 SEC filings?: You can read the 10-Q periodic report (0001213900-25-109980) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Oramed Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk